hit counter
Baxter International Inc. (BAX) Stock News Sentiment & Price - Sentifly
BAX - Sentifly


Profile

Watchlist

Your watchlist is empty. Go add some tickers to it!



Baxter International Inc. (BAX)

USA
Medical Instruments & Supplies
NYSE
BAX Price and Sentiment
1MO
1D
Positive, Negative
Loading chart...
BAX Latest news
Business Wire
Neutral
Baxter Announces $100 Million Investment in BioPharma Solutions Halle/Westfalen, Germany Sterile Fill/Finish Manufacturing Facility
2021-11-11 09:00

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter announced a $100M investment in its manufacturing facility in Halle/Westfalen, Germany that will add new capacity and capabilities.

Business Wire
Neutral
Baxter Highlights New Data Indicating Sharesource Digital Health Platform for Home Dialysis May Improve Survival and Reduce Hospitalizations
2021-11-08 08:30

DEERFIELD, Ill.--(BUSINESS WIRE)-- #digitalhealth--Baxter International Inc. (NYSE:BAX), a global innovator in renal care, announced today new data showing kidney patients may experience a survival rate nearly two-times higher and a prolonged time to an adverse event (AE) and hospitalization when the Sharesource remote patient management digital health platform is used to help manage home automated peritoneal dialysis (APD).1 The new data was presented during the American Society of Nephrology's annual Kidney W

Business Wire
Neutral
Baxter to Present at Evercore ISI 4th Annual HealthCONx Conference
2021-11-02 16:15

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, will present at the Evercore ISI 4th Annual HealthCONx Conference on Thursday, December 2, 2021. Jay Saccaro, Baxter's chief financial officer, is scheduled to present at 9:40 a.m. Eastern Time. The live webcast of Baxter's presentation can be accessed at www.baxter.com and will be available for replay through May 21, 2022. About Baxter Every day, millions of patients and caregiver

Benzinga
Negative
Baxter Shares Fall Despite Better-Than-Expected Q3 Earnings, FY21 EPS Outlook Boost
2021-10-28 15:37

Baxter International Inc (NYSE: BAX) posted Q3 revenue of $3.23 billion, in line with the consensus, up 9% on a reported basis, 7% on a constant currency basis, and 6% on an operational basis. Adjusted EPS of $1.02 increased 23% and surpassed the estimate of $0.94.

Seeking Alpha
Neutral
Baxter International Inc. (BAX) CEO Joe Almeida on Q3 2021 Results - Earnings Call Transcript
2021-10-28 13:41

Baxter International Inc. (BAX) CEO Joe Almeida on Q3 2021 Results - Earnings Call Transcript

Zacks Investment Research
Positive
Baxter (BAX) Q3 Earnings and Revenues Surpass Estimates
2021-10-28 11:29

Baxter's (BAX) third-quarter results reflect robust performance across all its business units.

Zacks Investment Research
Positive
Baxter International (BAX) Q3 Earnings and Revenues Beat Estimates
2021-10-28 09:57

Baxter (BAX) delivered earnings and revenue surprises of 8.51% and 0.05%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

Business Wire
Neutral
Baxter Reports Third-Quarter 2021 Results
2021-10-28 07:15

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leading global medical products company, today reported results for the third quarter of 2021. “Baxter's essential products, diverse portfolio and global scale continue to fuel our operations in 2021,” said José (Joe) E. Almeida, chairman, president and chief executive officer. “This month marks Baxter's 90th anniversary. Our employees have been at the heart of our success for nine decades and remain as determined as ever

Zacks Investment Research
Neutral
Baxter (BAX) to Report Q3 Earnings: What's in the Offing?
2021-10-22 12:50

Baxter's (BAX) third-quarter results are likely to reflect growth in its Acute Therapies business.

Zacks Investment Research
Neutral
Baxter International (BAX) Earnings Expected to Grow: Should You Buy?
2021-10-21 17:24

Baxter (BAX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Loading more news...